G

Guilin Sanjin Pharmaceutical Co Ltd
SZSE:002275

Watchlist Manager
Guilin Sanjin Pharmaceutical Co Ltd
SZSE:002275
Watchlist
Price: 14.68 CNY 0.27% Market Closed
Market Cap: ¥8.6B

Wall Street
Price Targets

Price Targets Summary
Guilin Sanjin Pharmaceutical Co Ltd

There are no price targets for Guilin Sanjin Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Guilin Sanjin Pharmaceutical Co Ltd Competitors:
Price Targets
SONO
Sonos Inc
25% Upside
PLRX
Pliant Therapeutics Inc
155% Upside

Revenue
Forecast

5% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
5% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

For the last 13 years the compound annual growth rate for Guilin Sanjin Pharmaceutical Co Ltd's revenue is 5%. The projected CAGR for the next 2 years is 13%.

Operating Income
Forecast

4% / Year
Past Growth
15% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
4% / Year
Past Growth
15% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 13 years the compound annual growth rate for Guilin Sanjin Pharmaceutical Co Ltd's operating income is 4%. The projected CAGR for the next 2 years is 15%.

Net Income
Forecast

5% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss
5% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss

For the last 13 years the compound annual growth rate for Guilin Sanjin Pharmaceutical Co Ltd's net income is 5%. The projected CAGR for the next 2 years is 5%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Guilin Sanjin Pharmaceutical Co Ltd's stock price target?
Not Available

Guilin Sanjin Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Guilin Sanjin Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
13%

For the last 13 years the compound annual growth rate for Guilin Sanjin Pharmaceutical Co Ltd's revenue is 5%. The projected CAGR for the next 2 years is 13%.

What is Guilin Sanjin Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
15%

For the last 13 years the compound annual growth rate for Guilin Sanjin Pharmaceutical Co Ltd's operating income is 4%. The projected CAGR for the next 2 years is 15%.

What is Guilin Sanjin Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
5%

For the last 13 years the compound annual growth rate for Guilin Sanjin Pharmaceutical Co Ltd's net income is 5%. The projected CAGR for the next 2 years is 5%.

Back to Top